Synergistic cytotoxic effect of cisplatin and monoclonal anti-Fas IPO-4 antibodies on human epidermoid carcinoma cell line KB

Experimental Oncology

Volumn 20, Issue 3-4, 1998, Pages 210-216

  Chekhun, V F ^a   Shishova, Yu V ^a   Yurchenko, O V ^a   Shlapatskaya, L N ^a   Mikhalap, S V ^a   Berdova, A G ^a   Sidorenko, S P ^a   Kulik, G I ^a   Gluzman, D F ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Apoptosis; Cisplatin; Fas antigen; Monoclonal antibody

Indexed keywords

CISPLATIN; FAS ANTIBODY; FAS ANTIGEN; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY IPO 4; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; HUMAN; HUMAN CELL; SQUAMOUS CELL CARCINOMA;

EID: 0032430835     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Micheau O, Solary E, Hamman A, Martin F, Dimanche-Boitrel MT. Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity. J Natl Cancer Inst 1997; 11: 783-9.
2. Leverkus M, Yaar M, Gilchrest BA. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 1997; 232: 255-62
3. Sugimoto C, Matsukawa Sh, Fujieda Sh, Noda J, Tanaka N, Tsuzuki H, Saito H. Involvement of intracellular glutathione in induction of apoptosis by cisplatin in a human pharyngeal carcinoma cell line. Anticancer Res 1996; 16: 675-80.
4. Henkels KM, Turchi JJ. Induction of apoptosis in cisplatin-sensitive and resistant human ovarian cancer cell lines. Cancer Res. 1997; 57: 4488-92
5. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA, Cohen MB. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 1997; 57: 1758-68.
6. Uslu R, Jewett A, Bonavida B. Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-Fas antibody-mediated cytotoxicity and apoptosis. Gynecol Oncol 1996; 62: 282-91.
7. Fulda S, Seiverts H, Friesen C, Herr J, Debatin KM. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 1997; 57: 3823-9.
8. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Grell R. Drug induced apoptosis is associated with enhanced Fas/(APO-1/CD95) signalling in human T-acute lymphatic leukemia cells. Cancer Res 1997; 57: 3331-4.
9. Wakahara F, Nawa A, Okamoto T, Hayakawa A, Kikkawa F, Suganama N, Wakahara F, Tomada Y. Combination effecy of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro. Oncology 1997; 54: 48-54.
10. Frost P, Ng CP, Belldergun A, Bonavida B. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity. Cell Immunol 1997; 180: 70-83.
11. Mizutani Y, Yoshida O, Bonavida B. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum. J Urol 1998; 160: 561-70.
12. Juft JH. Improvements in epoxyresin embedding methods. J Biophys Biochem Cytol 1961; 9: 409-14.
13. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ, Kaufmann SH. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 1997; 90: 935-43.
14. Takeda M, Kobayashi M, Shirate J, Osaki T, Endou H. Cisplatin-induced apoptosis of immortalized mouse proximal tubule cells is mediated by interleukin -1 beta converting enzyme (ICE) family of proteases but inhibited by overexpression of bcl-2. Arch Toxicol 1997; 71: 612-21.
15. Eichholtz-Wirth H, Stoetzer O, Marx K. Reduced expression of the ICE-related protease CPP 32 is associated with radiation-induced cisplatin resistance in HeLa cells. Br J Cancer 1997; 76: 1322-7.
16. Chen Z, Naito M, Mashima T, Tsuruo T. Activation of actin-cleavable interleukin 1 beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res 1996; 56: 5224-9.
17. Delmastro DA, Li J, Vaisman A, Solle M, Chaney SG. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 1997; 39: 245-53.